Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
2. Bilateral abnormalities in neuropathic pain 95% Confidence Intervals confirmed that the prevalence of normal sensory function differs significantly between healthy controls and patients at the painful and non-painful side (all p
2. Bilateral abnormalities in neuropathic pain 3.3.2. Sensory changes at patients affected side Sensory abnormalities at the affected side ranged from 7.4% (n=5) for WUR to 48.1% (n=39) for PPT. 95% Confidence Intervals confirmed that the prevalence differed significantly from zero (p
- Page 2: Quantitative Sensory Testing (QST)
- Page 5 and 6: Promotores: Prof. dr. M.M.R.F. Stru
- Page 7 and 8: Paranimfen Marten Harbers Aribert B
- Page 9 and 10: Contents 3.3.4. Sensory changes at
- Page 11: 0 Contents Chapter 5 Do patients wi
- Page 14: Chapter 1 General introduction
- Page 17 and 18: 1. General introduction stimuli. C-
- Page 19 and 20: 1. General introduction Patients re
- Page 21 and 22: 1. General introduction 0 drugs (NS
- Page 23 and 24: 1. General introduction Table 1-2:
- Page 26 and 27: Chapter 2 Bilateral sensory abnorma
- Page 28 and 29: 2. Bilateral abnormalities in neuro
- Page 30 and 31: 2. Bilateral abnormalities in neuro
- Page 32 and 33: 2. Bilateral abnormalities in neuro
- Page 34 and 35: 2. Bilateral abnormalities in neuro
- Page 38 and 39: 2. Bilateral abnormalities in neuro
- Page 40 and 41: 2. Bilateral abnormalities in neuro
- Page 42 and 43: 2. Bilateral abnormalities in neuro
- Page 44 and 45: 2. Bilateral abnormalities in neuro
- Page 46: 2. Bilateral abnormalities in neuro
- Page 49 and 50: 3. Somatosensory function and neuro
- Page 51 and 52: 0 3. Somatosensory function and neu
- Page 53 and 54: 3. Somatosensory function and neuro
- Page 55 and 56: 3. Somatosensory function and neuro
- Page 57 and 58: 3. Somatosensory function and neuro
- Page 59 and 60: 3. Somatosensory function and neuro
- Page 61 and 62: 3. Somatosensory function and neuro
- Page 63 and 64: 3. Somatosensory function and neuro
- Page 65 and 66: 3. Somatosensory function and neuro
- Page 67 and 68: 4. QST and neuropathic pain mechani
- Page 69 and 70: 4. QST and neuropathic pain mechani
- Page 71 and 72: 4. QST and neuropathic pain mechani
- Page 73 and 74: 4. QST and neuropathic pain mechani
- Page 75 and 76: 4. QST and neuropathic pain mechani
- Page 77 and 78: 4. QST and neuropathic pain mechani
- Page 79 and 80: 4. QST and neuropathic pain mechani
- Page 81 and 82: 5. QST in patients with tendinopath
- Page 83 and 84: 5. QST in patients with tendinopath
- Page 85 and 86: 5. QST in patients with tendinopath
2. Bilateral abnormalities in neuropathic pain<br />
3.3.2. <strong>Sensory</strong> changes at patients affected side<br />
<strong>Sensory</strong> abnormalities at the affected side ranged from 7.4% (n=5) for WUR to 48.1%<br />
(n=39) for PPT. 95% Confidence Intervals confirmed that the prevalence differed<br />
significantly from zero (p
Change language